ATA286178A - METHOD FOR PRODUCING THYMOSINE ALFA1 OR ITS (ASN2) ANALOG - Google Patents

METHOD FOR PRODUCING THYMOSINE ALFA1 OR ITS (ASN2) ANALOG

Info

Publication number
ATA286178A
ATA286178A AT286178A AT286178A ATA286178A AT A286178 A ATA286178 A AT A286178A AT 286178 A AT286178 A AT 286178A AT 286178 A AT286178 A AT 286178A AT A286178 A ATA286178 A AT A286178A
Authority
AT
Austria
Prior art keywords
alfa1
thymosine
asn2
analog
producing
Prior art date
Application number
AT286178A
Other languages
German (de)
Other versions
AT364470B (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/871,563 external-priority patent/US4116951A/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ATA286178A publication Critical patent/ATA286178A/en
Application granted granted Critical
Publication of AT364470B publication Critical patent/AT364470B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT0286178A 1977-04-22 1978-04-21 METHOD FOR PRODUCING THYMOSINE ALFA1 OR ITS (ASN2) ANALOG AT364470B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78989877A 1977-04-22 1977-04-22
US05/871,563 US4116951A (en) 1977-04-22 1978-01-23 [Asn2 ]-thymosin α1 and analogs thereof

Publications (2)

Publication Number Publication Date
ATA286178A true ATA286178A (en) 1981-03-15
AT364470B AT364470B (en) 1981-10-27

Family

ID=27120967

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0286178A AT364470B (en) 1977-04-22 1978-04-21 METHOD FOR PRODUCING THYMOSINE ALFA1 OR ITS (ASN2) ANALOG

Country Status (18)

Country Link
JP (1) JPS53137914A (en)
AT (1) AT364470B (en)
CA (1) CA1113088A (en)
CH (3) CH641152A5 (en)
DE (1) DE2817082A1 (en)
DK (1) DK147918C (en)
ES (1) ES469016A1 (en)
FI (1) FI781241A (en)
FR (2) FR2401134A1 (en)
GB (1) GB1590668A (en)
GR (1) GR71886B (en)
HU (1) HU180783B (en)
IT (1) IT1113134B (en)
LU (1) LU79488A1 (en)
NL (1) NL7804364A (en)
NO (2) NO781404L (en)
PT (1) PT67937B (en)
SE (1) SE447262B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4116951A (en) * 1977-04-22 1978-09-26 Hoffmann-La Roche Inc. [Asn2 ]-thymosin α1 and analogs thereof
DE2919592A1 (en) * 1979-05-15 1981-01-15 Max Planck Gesellschaft METHOD FOR PRODUCING THYMOSINE ALPHA 1 AND DERIVATIVES THEREOF
EP0033384B1 (en) * 1980-01-18 1984-02-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Medicaments containing fragments of thymosin-alpha-1 with immunostimulating activity, and thymosin-alpha-1 fragments
US4339427A (en) * 1980-04-14 1982-07-13 Hoffmann-La Roche Inc. Radioimmunoassay of thymosinα
EP0056594B1 (en) * 1981-01-14 1984-09-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1 fragments and pharmaceutical compositions with immunoregulating action containing them
CN1058500C (en) * 1993-02-03 2000-11-15 施塞克龙药品公司 Thymosin alpha-1 derivatives
US6262230B1 (en) * 1994-01-28 2001-07-17 Sciclone Pharmaceuticals Inc. Analogs of thymosin α1

Also Published As

Publication number Publication date
CH641153A5 (en) 1984-02-15
AT364470B (en) 1981-10-27
PT67937A (en) 1978-05-01
NO148924C (en) 1984-01-11
NO148924B (en) 1983-10-03
FR2401134A1 (en) 1979-03-23
FI781241A (en) 1978-10-23
NO781404L (en) 1978-10-24
IT7822629A0 (en) 1978-04-21
CH640218A5 (en) 1983-12-30
SE447262B (en) 1986-11-03
JPS53137914A (en) 1978-12-01
SE7804612L (en) 1978-12-20
GB1590668A (en) 1981-06-03
PT67937B (en) 1980-04-07
IT1113134B (en) 1986-01-20
DK147918C (en) 1985-08-19
FR2401134B1 (en) 1983-09-30
ES469016A1 (en) 1980-01-01
DK147918B (en) 1985-01-07
FR2405926A1 (en) 1979-05-11
FR2405926B1 (en) 1983-09-09
DK169478A (en) 1978-10-23
HU180783B (en) 1983-04-29
NL7804364A (en) 1978-10-24
CH641152A5 (en) 1984-02-15
LU79488A1 (en) 1979-05-25
CA1113088A (en) 1981-11-24
NO821608L (en) 1978-10-24
DE2817082A1 (en) 1978-11-02
GR71886B (en) 1983-08-04

Similar Documents

Publication Publication Date Title
AT367438B (en) METHOD FOR PRODUCING OLIGOIMIDES
AT356096B (en) METHOD FOR PRODUCING FUROKUMARINES
AT358548B (en) METHOD FOR PRODUCING 2-AETHYLHEXANOL
AT358559B (en) METHOD FOR PRODUCING O-METHALLYLOXY-PHENOL
AT359283B (en) METHOD FOR PRODUCING FASTENERS
AT360504B (en) METHOD FOR PRODUCING M-CHLORANILINE
AT366032B (en) METHOD FOR PRODUCING MORANOLINE AND N-METHYLMORANOLINE
AT356643B (en) METHOD FOR PRODUCING ACYLCYANIDES
AT364470B (en) METHOD FOR PRODUCING THYMOSINE ALFA1 OR ITS (ASN2) ANALOG
AT360652B (en) METHOD FOR PRODUCING 3-IODINE AND 3- BRROMIFIFYCIN S
AT360154B (en) METHOD FOR PRODUCING AMINOGLYCOSIDE- -ANTIBIOTKA
AT377741B (en) METHOD FOR PRODUCING CHLORDIOXIDE
DD133661A1 (en) PROCESS FOR PREPARING AETHERS AND / OR AETHERAL COCOOLS
AT347440B (en) METHOD FOR PRODUCING BENZOYLCYANIDE
AT360648B (en) METHOD FOR PRODUCING P-HYDROXY-ALPHA- -AMINOBENZYLPENICILLIN
AT356642B (en) METHOD FOR PRODUCING ACYLCYANIDES
AT365590B (en) METHOD FOR PRODUCING APOVINCAMINE
AT366036B (en) METHOD FOR PRODUCING 3-PYRIDAZONES
AT359483B (en) METHOD FOR PRODUCING BENZOYLCYANIDE
AT352104B (en) METHOD FOR PRODUCING N-CYANOALKYL-P-HALOGENPHENOXY ISOBUTYRAMIDES
AT368523B (en) METHOD FOR PRODUCING BUFADIENOLID AND BUFATRIENOLIDAETHERS
AT359510B (en) METHOD FOR PRODUCING BENZYLPYRIMIDINES
AT361497B (en) METHOD FOR PRODUCING ALKYLTHIOSEMICARBAZIDES
AT358021B (en) METHOD FOR PRODUCING BENZOYLCYANIDE
AT362084B (en) METHOD FOR PRODUCING 10-BROMVINCAMINE

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee